SERPINB5 and lung carcinoma: Others hold MASPIN inhibits cell motility by suppressing Rac1 and PAK1 activity [47], promotes cell adhesion via the PI3K/ERK pathway [47,48], and suppresses survival of lung cancer cells through modulation of AKT pathway [49,50].